Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality

Ghayas C. Issa, Hagop M. Kantarjian, Lianchun Xiao, Jing Ning, Yesid Alvarado, Gautam Borthakur, Naval Daver, Courtney D. DiNardo, Elias Jabbour, Prithviraj Bose, Nitin Jain, Tapan M. Kadia, Kiran Naqvi, Naveen Pemmaraju, Koichi Takahashi, Srdan Verstovsek, Micheal Andreeff, Steven M. Kornblau, Zeev Estrov, Alessandra FerrajoliGuillermo Garcia-Manero, Maro Ohanian, William G. Wierda, Farhad Ravandi, Jorge E. Cortes

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality'. Together they form a unique fingerprint.

Medicine & Life Sciences